Minimally invasive application of botulinum toxin type A in nasal hypersecretion

ORL

Volumn 63, Issue 6, 2001, Pages 382-384

  Rohrbach, Saskia ^a,b   Laskawi, Rainer ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Botulinum toxin; Minimally invasive application; Nasal hypersecretion

Indexed keywords

ANTIHISTAMINIC AGENT; BOTULINUM TOXIN A; DECONGESTIVE AGENT; STEROID;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FACIAL BONE; FEMALE; HUMAN; PRIORITY JOURNAL; RHINITIS; RHINOMANOMETRY; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; AGED; BOTULINUM TOXIN TYPE A; FEMALE; HUMANS; MUCUS; NEUROMUSCULAR AGENTS; RHINITIS;

EID: 0035175427     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055778     Document Type: Article

References (9)

1. International consensus report on the diagnosis and management of rhinitis
2. The effect of botulinum toxin type A injection for intrinsic rhinitis
3. Botulinum toxin treatment in patients with hemifacial spasm
4. Up-to-date report of botulinum toxin type A treatment on patients with gustatory sweating (Frey's syndrome)
5. Treatment of gustatory sweating with botulinum toxin: Special aspects
6. Rhinorrhoea is decreased in dogs after nasal application of botulinum toxin
7. Botulinum toxin induces apoptosis in nasal glands of guinea pigs
8. Botox-induced prostatic involution
9. Histologic feature of human orbicularis oculi treated with botulinum toxin